<DOC>
	<DOC>NCT02791750</DOC>
	<brief_summary>Non-persistence to adjuvant hormonal therapy for breast cancer at 5 years decrease its efficacy. The objective of this study is to know the women experience (persistence, treatment changes, quality of life) and its determinants, in a french population.</brief_summary>
	<brief_title>5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma</brief_title>
	<detailed_description />
	<criteria>Patients followingup in the Lorraine Institute of Oncology at 5 years of the beginning of an adjuvant hormonal therapy Women with breast invasive carcinoma positiveRH and indication of adjuvant hormonal therapy Adult patients Being capable and agree to follow the study procedure Patients informed and nonopposed Covered by social security History of other cancer except basal cell carcinoma Patients with breast invasive carcinoma negativeRH Synchronous metastases Relapsed Previous adjuvant hormonal therapy Men Patients with guardianship</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hormone replacement therapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>follow up</keyword>
</DOC>